Equivocal (HER2 IHC 2+) breast carcinomas: gene-protein assay testing reveals association between genetic heterogeneity, individual cell amplification status and potential treatment benefits-Reference-Cited by-同舟云学术

Equivocal (HER2 IHC 2+) breast carcinomas: gene-protein assay testing reveals association between genetic heterogeneity, individual cell amplification status and potential treatment benefits

Published:2018-11-11 Issue:2 Volume:74 Page:300-310
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Pekar Gyula¹^ORCID,Kasselaki Ionna¹,Pekar-Lukacs Agnes¹,Dekany Csaba¹,Hellberg Dan²,Tot Tibor³

Affiliation:

1. Department of Oncology and Pathology; Lund University; Lund Sweden

2. Department for Women's and Children's Health; Uppsala University; Uppsala Sweden

3. Pathology and Cytology; County Hospital Falun; Falun Sweden

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/his.13733/fullpdf

Reference33 articles.

1. Current challenges for HER2 testing in diagnostic pathology: state of the art and controversial issues;Sapino;Front. Oncol.,2013

2. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N. Engl. J. Med.,2001

3. Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31;Pogue-Geile;J. Natl Cancer Inst.,2013

4. A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections;Nitta;Diagn. Pathol.,2012

5. Dual HER2 gene protein assay: focused study of breast cancers with 2+ immunohistochemical expression;Li;Am. J. Clin. Pathol.,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Evolution of Targeted Radionuclide Diagnosis of HER2-Positive Breast Cancer;Acta Naturae;2022-07-21

2. Pathological Diagnosis, Work-Up and Reporting of Breast Cancer 1st Central-Eastern European Professional Consensus Statement on Breast Cancer;Pathology and Oncology Research;2022-06-27

3. Somatic mutations and copy number variations in breast cancers with heterogeneousHER2amplification;Molecular Oncology;2020-04

4. Internodal HER2 heterogeneity of axillary lymph node metastases in breast cancer patients;Bosnian Journal of Basic Medical Sciences;2019-04-02

5. gene amplification as a mechanism of clonal heterogeneity in breast cancer;Arkhiv patologii;2019